Quince Therapeutics, Inc. QNCX
31.73 USD +2.37 (+8.07%)
At closeOct 9, 2026, 4:00 PM EDT
32.00 +0.27 +0.85%
After hours · Oct 9, 4:00 PM ET
29.84 Day range 37.00
0.512 52-week range 2.45
- YTD
- -95.26%
- 1 year
- -91.82%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -50.43M | -53.30M | -33.04M | -52.02M | -90.32M | |
| -83.98M | -56.83M | -31.39M | -51.66M | -89.94M | |
| -336.00 | -262.00 | -168.00 | -308.00 | -606.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 5.81M | 6.21M | 20.75M | 44.58M | 69.72M | |
| 93.52M | 114.48M | 167.90M | 103.91M | 133.23M | |
| 129.24M | 84.33M | 82.82M | 3.32M | 14.64M | |
| 18.36M | 14.71M | 13.75M | 0 | 420.00K | |
| -35.71M | 30.15M | 85.08M | 100.59M | 118.59M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -41.42M | -31.90M | -18.29M | -44.04M | -62.93M | |
| 23.23M | 21.91M | -5.76M | 18.00M | 58.95M | |
| 17.91M | -4.78M | 143.00K | 707.00K | 6.81M | |
| -352.00K | -257.00K | -70.00K | -63.00K | -180.00K | |
| -403.00K | -14.54M | -23.83M | -25.14M | 2.88M |